Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF660 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
mRNA | C18orf32 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-09 |
mRNA | GRIK5 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | CRMP1 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
mRNA | VPS4B | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
mRNA | RMND5A | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
mRNA | STXBP5L | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |
mRNA | ZNF407 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | RP3-403A15.5 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
mRNA | KIAA1468 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-10 |